UNSPSC 51112300: Alkylating agent alkanesulfonic acids

This classification denotes sulfonic acid derivatives that are substituted with an aliphatic hydrocarbon group, substances called alkanesulfonic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term ALKYLATING AGENT ALKANESULFONIC ACIDS.

UNSPSC 51112300 Alkylating agent alkanesulfonic acids is a Class code that covers pharmaceutical chemical compounds used in medical and therapeutic applications. State and local government procurement under this code centers on acquisition of these specialized chemical agents for use within health and human services programs, particularly pharmacy benefit administration and direct-to-manufacturer prescription initiatives. The issuing bodies soliciting under this code are typically state health and human services agencies managing pharmacy programs for employee benefit plans and Medicaid or other public health programs. These procurements often involve exploratory or market-intelligence phases before formal competitive solicitations, as demonstrated by recent activity in the space.

The Texas Health and Human Services Commission (HHS) posted Request for Information (RFI) HHS0017013 on April 3, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative (TPI) Direct-to-Manufacturer Prescriptions program. The RFI solicits information from vendors regarding their capacity to establish direct contracts with self-insured employee group health plans and state agencies, implement value-based or outcomes-based pricing models, and manage prescription fulfillment outside traditional pharmacy benefit manager and group purchasing organization channels. The response deadline was April 3, 2026. No award value, set-asides, or formal evaluation criteria were specified in the RFI materials, reflecting its character as a preliminary information-gathering tool to inform the state's subsequent formal procurement strategy and program design. Limited recent activity in the public record suggests this code sees modest solicitation volume at the state and local level; the single identified opportunity indicates early-stage market development by Texas HHS rather than routine or high-frequency procurement cycles under the code.